Trust Company of Vermont’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$247K Hold
470
0.01% 318
2025
Q1
$298K Hold
470
0.01% 293
2024
Q4
$335K Buy
470
+313
+199% +$223K 0.02% 291
2024
Q3
$165K Buy
157
+12
+8% +$12.6K 0.01% 355
2024
Q2
$152K Buy
145
+123
+559% +$129K 0.01% 350
2024
Q1
$21.2K Buy
22
+20
+1,000% +$19.3K ﹤0.01% 615
2023
Q4
$1.76K Sell
2
-20
-91% -$17.6K ﹤0.01% 703
2023
Q3
$18.1K Hold
22
﹤0.01% 586
2023
Q2
$15.8K Sell
22
-2
-8% -$1.44K ﹤0.01% 616
2023
Q1
$19.7K Buy
24
+2
+9% +$1.64K ﹤0.01% 603
2022
Q4
$15.9K Hold
22
﹤0.01% 610
2022
Q3
$15K Hold
22
﹤0.01% 646
2022
Q2
$13K Buy
+22
New +$13K ﹤0.01% 649
2022
Q1
Sell
-24
Closed -$16K 644
2021
Q4
$16K Buy
+24
New +$16K ﹤0.01% 612
2021
Q3
Sell
-24
Closed -$13K 616
2021
Q2
$13K Buy
24
+4
+20% +$2.17K ﹤0.01% 619
2021
Q1
$9K Sell
20
-5
-20% -$2.25K ﹤0.01% 643
2020
Q4
$12K Hold
25
﹤0.01% 609
2020
Q3
$14K Hold
25
﹤0.01% 570
2020
Q2
$15K Buy
25
+5
+25% +$3K ﹤0.01% 574
2020
Q1
$10K Sell
20
-15
-43% -$7.5K ﹤0.01% 660
2019
Q4
$14K Hold
35
﹤0.01% 668
2019
Q3
$10K Buy
35
+15
+75% +$4.29K ﹤0.01% 747
2019
Q2
$6K Hold
20
﹤0.01% 820
2019
Q1
$8K Sell
20
-20
-50% -$8K ﹤0.01% 747
2018
Q4
$14K Sell
40
-50
-56% -$17.5K ﹤0.01% 681
2018
Q3
$36K Hold
90
﹤0.01% 570
2018
Q2
$31K Buy
90
+66
+275% +$22.7K ﹤0.01% 610
2018
Q1
$8K Hold
24
﹤0.01% 782
2017
Q4
$10K Hold
24
﹤0.01% 762
2017
Q3
$11K Sell
24
-3
-11% -$1.38K ﹤0.01% 723
2017
Q2
$13K Buy
27
+3
+13% +$1.44K ﹤0.01% 703
2017
Q1
$10K Hold
24
﹤0.01% 711
2016
Q4
$8K Buy
+24
New +$8K ﹤0.01% 731